Copenhagen, Denmark

Tomas Norling


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tomas Norling

Introduction

Tomas Norling is a notable inventor based in Copenhagen, Denmark. He has made significant strides in the field of controlled delivery systems for biologically active agents. His work focuses on improving the efficacy of pharmaceutical treatments, particularly in the realm of periodontal disease.

Latest Patents

Tomas Norling holds a patent for a method and composition for controlled delivery of biologically active agents. This innovative approach combines a monoglyceride and a vegetable oil to create a composition that forms a reverse hexagonal liquid crystalline phase matrix upon contact with an aqueous liquid. This matrix allows for the controlled release of active agents, making it particularly useful for treating periodontal disease. The composition can be inserted directly into the periodontal pocket, where it utilizes gingival fluid to induce the formation of the liquid crystalline phase matrix in situ.

Career Highlights

Throughout his career, Tomas has demonstrated a commitment to advancing pharmaceutical delivery methods. His work at A/S Dumex has positioned him as a key player in the development of innovative solutions for medical challenges. His patent reflects his dedication to improving patient outcomes through scientific innovation.

Collaborations

Tomas collaborates with talented professionals such as Pia Lading and Yvonne Lundsholm. Their combined expertise contributes to the success of their projects and enhances the research environment at A/S Dumex.

Conclusion

Tomas Norling's contributions to the field of controlled delivery systems exemplify the impact of innovative thinking in medicine. His patent showcases a promising method for enhancing the treatment of periodontal disease, highlighting the importance of continued research and development in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…